4.5 Article

Genetic study of BDNF, DRD3, and their interaction in tardive dyskinesia

期刊

EUROPEAN NEUROPSYCHOPHARMACOLOGY
卷 19, 期 5, 页码 317-328

出版社

ELSEVIER
DOI: 10.1016/j.euroneuro.2009.01.001

关键词

Schizophrenia; Tardive dyskinesia; Pharmacogenetics; BDNF; DRD3; Abnormal Involuntary; Movement Scale (AIMS)

资金

  1. CIHR

向作者/读者索取更多资源

Tardive dyskinesia (TD) is a neuroleptic-induced movement disorder. Its pathophysiology is unclear. The most consistent genetic findings have shown an association with the Ser9Gly polymorphism of the DRD3 gene. However, only few polymorphisms within DRD3 has been tested, and a comprehensive examination of DRD3 in TD is still tacking. Further, brain-derived neurotrophic factor (BDNF), a neuronal growth and survival peptide, regulates DRD3 expression and may be involved in the neuronal degeneration observed in TD. In the present study, we investigated 15 tag DRD3 polymorphisms and four tag BDNF polymorphisms for association with TD in our sample of Caucasian schizophrenia patients (N = 171). White BDNF markers showed no association, a haplotype containing rs3732782, rs905568, and rs7620754 in the 5' region of DRD3 was associated with TD diagnosis (p[10,000 permutations] = 0.007). We also found evidence of interaction between BDNF and DRD3 polymorphisms. Further studies are needed to confirm these findings. (C) 2009 Elsevier B.V. and ECNP. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据